Iona College and NewYork-Presbyterian today announced the establishment of the NewYork-Presbyterian Iona School of Health Sciences, to be principally located on the College's campus at 171 White Plains Road, Bronxville, New York.
Endologix LLC, a leader in the treatment of vascular disease, today announced the company’s ChEVAS™ (Chimney EndoVascular Aneurysm Sealing) System has been granted a Breakthrough Device Designation from the U.S.
Accure Health, a developer of rapid digital diagnostics, today announced the online publication of preliminary data showing that its novel saliva assay can assess individual immune response to COVID-19 vaccines, monitor neutralizing antibody levels over time, and model immune protection against SARS-Cov-2 variants.
Palliare, an emerging company with the vision to create a safer operating room, today announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends the capabilities of its EVA15 continuous pressure insufflation technology from laparoscopic surgery to endoscopic and endoluminal surgery.
RTI Surgical, a leading surgical implant company providing blue-chip OEM customers with a portfolio of tissue-based, synthetic and metal implants, has today announced it has entered in a long-term strategic agreement with leading global medical device OEM Exactech, related to the development and supply of biologic bone substitutes.
Medical device and technology company Lazurite™ will unveil its transformative ArthroFree™ wireless arthroscopic camera system at the combined annual meeting of the American Orthopedic Society for Sport Medicine (AOSSM) and the Arthroscopy Association of North America (AANA) at Music City Center in Nashville, Tenn., July 7-11, 2021.
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED™ 62 Reperfusion Catheter, the latest addition to the company’s comprehensive Penumbra System®.
The Tru-D® UVC disinfection device has been shown to be effective against Candida auris and Candida albicans in both direct and indirect line of sight, according to a new study, "Inactivation of Candida auris and Candida albicans by ultraviolet-C," in Infection Control and Hospital Epidemiology (ICHE).
Aspen Surgical Products, Inc. (“Aspen”), a leader in surgical disposable products, announced the acquisition of Stork® (“Stork”), a division of Briggs Healthcare.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) announced today that its second-generation iQ+ has been approved for a Class III Medical Device License in Canada.